Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP921812.RAcinHNz_lCzHXC-GYoWlCNmA2l19wXUZb_NjWBftyT38130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP921812.RAcinHNz_lCzHXC-GYoWlCNmA2l19wXUZb_NjWBftyT38130_assertion type Assertion NP921812.RAcinHNz_lCzHXC-GYoWlCNmA2l19wXUZb_NjWBftyT38130_head.
- NP921812.RAcinHNz_lCzHXC-GYoWlCNmA2l19wXUZb_NjWBftyT38130_assertion description "[Taken together, the findings from this study identify F435-KOX as a novel and potent ZFP transcription factor that can inhibit VEGF-A-mediated angiogenesis and offer a novel therapeutic modality in the treatment of cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP921812.RAcinHNz_lCzHXC-GYoWlCNmA2l19wXUZb_NjWBftyT38130_provenance.
- NP921812.RAcinHNz_lCzHXC-GYoWlCNmA2l19wXUZb_NjWBftyT38130_assertion evidence source_evidence_literature NP921812.RAcinHNz_lCzHXC-GYoWlCNmA2l19wXUZb_NjWBftyT38130_provenance.
- NP921812.RAcinHNz_lCzHXC-GYoWlCNmA2l19wXUZb_NjWBftyT38130_assertion SIO_000772 18398429 NP921812.RAcinHNz_lCzHXC-GYoWlCNmA2l19wXUZb_NjWBftyT38130_provenance.
- NP921812.RAcinHNz_lCzHXC-GYoWlCNmA2l19wXUZb_NjWBftyT38130_assertion wasDerivedFrom befree-20150227 NP921812.RAcinHNz_lCzHXC-GYoWlCNmA2l19wXUZb_NjWBftyT38130_provenance.
- NP921812.RAcinHNz_lCzHXC-GYoWlCNmA2l19wXUZb_NjWBftyT38130_assertion wasGeneratedBy ECO_0000203 NP921812.RAcinHNz_lCzHXC-GYoWlCNmA2l19wXUZb_NjWBftyT38130_provenance.